English

AVALON PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2009-05-13

15 filing records in this dataset, filed from 2005-11-14 to 2009-05-13. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2009-03-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-3.33 million USD

2009-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -3326000 USD Source

Free cash flow

-3.33 million USD

2009-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -3326000 USD Source
Capital Expenditure: 5000 USD Source

Cash and cash equivalents: 3.46 million USD 2009-03-31 Source
Exact value

3458000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

261 thousand USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Revenue: 137000 USD · 2008-04-01 – 2008-06-30 Source
Revenue: 124000 USD · 2008-07-01 – 2008-09-30 Source
Revenue: 311000 USD · 2008-01-01 – 2008-12-31 Source
Revenue: 311000 USD · 2008-01-01 – 2008-09-30 Source
Revenue: 0 USD · 2009-01-01 – 2009-03-31 Source

Net income

-19.2 million USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Net income: -5578000 USD · 2008-04-01 – 2008-06-30 Source
Net income: -5959000 USD · 2008-07-01 – 2008-09-30 Source
Net income: -21827000 USD · 2008-01-01 – 2008-12-31 Source
Net income: -17786000 USD · 2008-01-01 – 2008-09-30 Source
Net income: -3602000 USD · 2009-01-01 – 2009-03-31 Source

Operating cash flow

-16.9 million USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Operating cash flow: -10410000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -4831000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -15580000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -10410000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -18436000 USD · 2008-01-01 – 2008-12-31 Source
Operating cash flow: -15580000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -3326000 USD · 2009-01-01 – 2009-03-31 Source

Capital expenditure

130 thousand USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Capital expenditure: 206000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 145000 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 245000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 206000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 270000 USD · 2008-01-01 – 2008-12-31 Source
Capital expenditure: 245000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 5000 USD · 2009-01-01 – 2009-03-31 Source

Free cash flow

-17.1 million USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Operating cash flow: -10410000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -4831000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -15580000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -10410000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -18436000 USD · 2008-01-01 – 2008-12-31 Source
Operating cash flow: -15580000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -3326000 USD · 2009-01-01 – 2009-03-31 Source
Capital expenditure: 206000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 145000 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 245000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 206000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 270000 USD · 2008-01-01 – 2008-12-31 Source
Capital expenditure: 245000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 5000 USD · 2009-01-01 – 2009-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-05-13.

Financial data available through: 2008-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2008-12-31
Operating income: 6 of 11 periods available· newest 2008-12-31
Net income: 6 of 11 periods available· newest 2008-12-31
Operating cash flow: 6 of 11 periods available· newest 2008-12-31
Capital expenditure: 6 of 11 periods available· newest 2008-12-31
Total assets: 5 of 11 periods available· newest 2008-12-31
Total liabilities: 2 of 11 periods available· newest 2008-12-31
Current assets: 5 of 11 periods available· newest 2008-12-31
Current liabilities: 5 of 11 periods available· newest 2008-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2008-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-61.6%

Prior period

USD 809,000

2007-01-01 – 2007-12-31
Current period

USD 311,000

2008-01-01 – 2008-12-31

Exact inputs and evidence

311000 − 809000 = -498000 USD

809000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
311000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · AVALON PHARMACEUTICALS INC · 2008-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Year-over-year change in Revenue: -498000 USD Concept: fundies:Revenue Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 311000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#6186 Input fundies:Revenue: 809000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#6186
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 154,000

Prior period

−USD 21.67 million

2007-01-01 – 2007-12-31
Current period

−USD 21.83 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

-21827000 − -21673000 = -154000 USD

-21673000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-21827000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AVALON PHARMACEUTICALS INC · 2008-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Year-over-year change in Net income: -154000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -21827000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7694 Input fundies:NetIncome: -21673000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7694
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 467,000

Prior period

−USD 18.9 million

2007-01-01 – 2007-12-31
Current period

−USD 18.44 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

-18436000 − -18903000 = 467000 USD

-18903000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-18436000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AVALON PHARMACEUTICALS INC · 2008-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Year-over-year change in Operating cash flow: 467000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -18436000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7902 Input fundies:OperatingCashFlow: -18903000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7902
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-36.8%

Prior period

USD 427,000

2007-01-01 – 2007-12-31
Current period

USD 270,000

2008-01-01 – 2008-12-31

Exact inputs and evidence

270000 − 427000 = -157000 USD

427000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
270000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · AVALON PHARMACEUTICALS INC · 2008-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Year-over-year change in Capital expenditure: -157000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 270000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7989 Input fundies:CapitalExpenditure: 427000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7989
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 311,000 100% of revenue
Operating costs Derived USD 22.3 million 7,171% of revenue
Operating income −USD 21.99 million −7,071% of revenue
Tax, interest and other Derived −USD 163,000 −52% of revenue
Net income −USD 21.83 million −7,018% of revenue

Cash

Operating cash flow −USD 18.44 million −5,928% of revenue
Capital expenditure USD 270,000 87% of revenue
Free cash flow Derived −USD 18.71 million −6,015% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2003 Operating loss: operating costs were 17,078% of revenue.
2004 Operating loss: operating costs were 790% of revenue.
2005 Operating loss: operating costs were 1,351% of revenue.
2006 Operating loss: operating costs were 768% of revenue.
2007 Operating loss: operating costs were 2,912% of revenue.
2008 Operating loss: operating costs were 7,171% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2003 2003-01-01 – 2003-12-31	100000	17078000 Derived	-16978000	98000 Derived	-17076000	-22372000 Derived	Source 2003-01-01 – 2003-12-31: 100000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -16978000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -17076000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -14884000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 7488000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	1900000	15004000 Derived	-13104000	555000 Derived	-13659000	-9942000 Derived	Source 2004-01-01 – 2004-12-31: 1900000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -13104000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -13659000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -9832000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 110000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	1544000	20855000 Derived	-19311000	-19000 Derived	-19292000	-13616000 Derived	Source 2005-01-01 – 2005-12-31: 1544000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -19311000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -19292000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -13373000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 243000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	2724000	20930000 Derived	-18206000	-1104000 Derived	-17102000	-12283000 Derived	Source 2006-01-01 – 2006-12-31: 2724000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -18206000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -17102000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -11932000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 351000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	809000	23562000 Derived	-22753000	-1080000 Derived	-21673000	-19330000 Derived	Source 2007-01-01 – 2007-12-31: 809000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -22753000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -21673000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -18903000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 427000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	311000	22301000 Derived	-21990000	-163000 Derived	-21827000	-18706000 Derived	Source 2008-01-01 – 2008-12-31: 311000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -21990000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -21827000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -18436000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 270000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 311K 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Revenue	100000	Revenue: 100000 Open source
20042004-12-31	Revenue	1900000	Revenue: 1900000 Open source
20052005-12-31	Revenue	1544000	Revenue: 1544000 Open source
20062006-12-31	Revenue	2724000	Revenue: 2724000 Open source
20072007-12-31	Revenue	809000	Revenue: 809000 Open source
20082008-12-31	Revenue	311000	Revenue: 311000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-61.6% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Year over year	No prior comparable period	Revenue: 100000 Open source
20042004-12-31	Year over year	1,800%	Revenue: 1900000 Open source Revenue: 100000 Open source
20052005-12-31	Year over year	-18.7%	Revenue: 1544000 Open source Revenue: 1900000 Open source
20062006-12-31	Year over year	76.4%	Revenue: 2724000 Open source Revenue: 1544000 Open source
20072007-12-31	Year over year	-70.3%	Revenue: 809000 Open source Revenue: 2724000 Open source
20082008-12-31	Year over year	-61.6%	Revenue: 311000 Open source Revenue: 809000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -7,070.7% 2008

Net margin -7,018.3% 2008

Free cash flow margin -6,014.8% 2008

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Operating margin	-16,978%	Operating Income: -16978000 Open source Revenue: 100000 Open source
20042004-12-31	Operating margin	-689.7%	Operating Income: -13104000 Open source Revenue: 1900000 Open source
20052005-12-31	Operating margin	-1,250.7%	Operating Income: -19311000 Open source Revenue: 1544000 Open source
20062006-12-31	Operating margin	-668.4%	Operating Income: -18206000 Open source Revenue: 2724000 Open source
20072007-12-31	Operating margin	-2,812.5%	Operating Income: -22753000 Open source Revenue: 809000 Open source
20082008-12-31	Operating margin	-7,070.7%	Operating Income: -21990000 Open source Revenue: 311000 Open source
20032003-12-31	Net margin	-17,076%	Net Income: -17076000 Open source Revenue: 100000 Open source
20042004-12-31	Net margin	-718.9%	Net Income: -13659000 Open source Revenue: 1900000 Open source
20052005-12-31	Net margin	-1,249.5%	Net Income: -19292000 Open source Revenue: 1544000 Open source
20062006-12-31	Net margin	-627.8%	Net Income: -17102000 Open source Revenue: 2724000 Open source
20072007-12-31	Net margin	-2,679%	Net Income: -21673000 Open source Revenue: 809000 Open source
20082008-12-31	Net margin	-7,018.3%	Net Income: -21827000 Open source Revenue: 311000 Open source
20032003-12-31	Free cash flow margin	-22,372%	Revenue: 100000 Open source Operating Cash Flow: -14884000 Open source Capital Expenditure: 7488000 Open source
20042004-12-31	Free cash flow margin	-523.3%	Revenue: 1900000 Open source Operating Cash Flow: -9832000 Open source Capital Expenditure: 110000 Open source
20052005-12-31	Free cash flow margin	-881.9%	Revenue: 1544000 Open source Operating Cash Flow: -13373000 Open source Capital Expenditure: 243000 Open source
20062006-12-31	Free cash flow margin	-450.9%	Revenue: 2724000 Open source Operating Cash Flow: -11932000 Open source Capital Expenditure: 351000 Open source
20072007-12-31	Free cash flow margin	-2,389.4%	Revenue: 809000 Open source Operating Cash Flow: -18903000 Open source Capital Expenditure: 427000 Open source
20082008-12-31	Free cash flow margin	-6,014.8%	Revenue: 311000 Open source Operating Cash Flow: -18436000 Open source Capital Expenditure: 270000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -18.4M 2008

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Operating cash flow	-14884000	Operating Cash Flow: -14884000 Open source
20042004-12-31	Operating cash flow	-9832000	Operating Cash Flow: -9832000 Open source
20052005-12-31	Operating cash flow	-13373000	Operating Cash Flow: -13373000 Open source
20062006-12-31	Operating cash flow	-11932000	Operating Cash Flow: -11932000 Open source
20072007-12-31	Operating cash flow	-18903000	Operating Cash Flow: -18903000 Open source
20082008-12-31	Operating cash flow	-18436000	Operating Cash Flow: -18436000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -18.7M 2008

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Free cash flow	-22372000	Operating Cash Flow: -14884000 Open source Capital Expenditure: 7488000 Open source
20042004-12-31	Free cash flow	-9942000	Operating Cash Flow: -9832000 Open source Capital Expenditure: 110000 Open source
20052005-12-31	Free cash flow	-13616000	Operating Cash Flow: -13373000 Open source Capital Expenditure: 243000 Open source
20062006-12-31	Free cash flow	-12283000	Operating Cash Flow: -11932000 Open source Capital Expenditure: 351000 Open source
20072007-12-31	Free cash flow	-19330000	Operating Cash Flow: -18903000 Open source Capital Expenditure: 427000 Open source
20082008-12-31	Free cash flow	-18706000	Operating Cash Flow: -18436000 Open source Capital Expenditure: 270000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

60.1% 2008

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2003-12-31	Liabilities / assets	Not reported	No source recorded
2004-12-31	Liabilities / assets	Not reported	Total Assets: 29292000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 41282000 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 31391000 Open source
20072007-12-31	Liabilities / assets	29.8%	Total Liabilities: 11131000 Open source Total Assets: 37305000 Open source
20082008-12-31	Liabilities / assets	60.1%	Total Liabilities: 7300000 Open source Total Assets: 12144000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.9× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2003-12-31	Current assets / current liabilities	Not reported	No source recorded
20042004-12-31	Current assets / current liabilities	2.69×	Current Assets: 8833000 Open source Current Liabilities: 3288000 Open source
20052005-12-31	Current assets / current liabilities	4.1×	Current Assets: 22584000 Open source Current Liabilities: 5514000 Open source
20062006-12-31	Current assets / current liabilities	2.53×	Current Assets: 14270000 Open source Current Liabilities: 5641000 Open source
20072007-12-31	Current assets / current liabilities	4.92×	Current Assets: 23069000 Open source Current Liabilities: 4685000 Open source
20082008-12-31	Current assets / current liabilities	0.9×	Current Assets: 6194000 Open source Current Liabilities: 6896000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2003 2003-01-01 – 2003-12-31	−USD 17.08 million Exact value Exact value: -17076000 USD 2003-01-01 – 2003-12-31: -17076000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON PHARMACEUTICALS INC · 2003-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Net Income: -17076000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17076000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-06-001598.txt#19912 The citation records this snapshot. The page link may show a newer release later.	−USD 14.88 million Exact value Exact value: -14884000 USD 2003-01-01 – 2003-12-31: -14884000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON PHARMACEUTICALS INC · 2003-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Operating Cash Flow: -14884000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14884000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-06-001598.txt#20660 The citation records this snapshot. The page link may show a newer release later.	USD 7.49 million Exact value Exact value: 7488000 USD 2003-01-01 – 2003-12-31: 7488000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVALON PHARMACEUTICALS INC · 2003-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Capital Expenditure: 7488000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7488000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-06-001598.txt#20879 The citation records this snapshot. The page link may show a newer release later.	−USD 22.37 million Calculation and evidence -14884000 − 7488000 USD Exact free cash flow: -22372000 USD 2003-01-01 – 2003-12-31: -14884000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 7488000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVALON PHARMACEUTICALS INC · 2003-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Free cash flow: -22372000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14884000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-06-001598.txt#20660 Input fundies:CapitalExpenditure: 7488000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-06-001598.txt#20879 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 13.66 million Exact value Exact value: -13659000 USD 2004-01-01 – 2004-12-31: -13659000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON PHARMACEUTICALS INC · 2004-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Net Income: -13659000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13659000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-07-001474.txt#13808 The citation records this snapshot. The page link may show a newer release later.	−USD 9.83 million Exact value Exact value: -9832000 USD 2004-01-01 – 2004-12-31: -9832000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON PHARMACEUTICALS INC · 2004-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Operating Cash Flow: -9832000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9832000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-07-001474.txt#20921 The citation records this snapshot. The page link may show a newer release later.	USD 110,000 Exact value Exact value: 110000 USD 2004-01-01 – 2004-12-31: 110000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVALON PHARMACEUTICALS INC · 2004-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Capital Expenditure: 110000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 110000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-07-001474.txt#21097 The citation records this snapshot. The page link may show a newer release later.	−USD 9.94 million Calculation and evidence -9832000 − 110000 USD Exact free cash flow: -9942000 USD 2004-01-01 – 2004-12-31: -9832000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 110000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVALON PHARMACEUTICALS INC · 2004-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Free cash flow: -9942000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9832000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-07-001474.txt#20921 Input fundies:CapitalExpenditure: 110000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-07-001474.txt#21097 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 19.29 million Exact value Exact value: -19292000 USD 2005-01-01 – 2005-12-31: -19292000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON PHARMACEUTICALS INC · 2005-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Net Income: -19292000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19292000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-08-001364.txt#20188 The citation records this snapshot. The page link may show a newer release later.	−USD 13.37 million Exact value Exact value: -13373000 USD 2005-01-01 – 2005-12-31: -13373000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON PHARMACEUTICALS INC · 2005-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Operating Cash Flow: -13373000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13373000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-08-001364.txt#20789 The citation records this snapshot. The page link may show a newer release later.	USD 243,000 Exact value Exact value: 243000 USD 2005-01-01 – 2005-12-31: 243000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVALON PHARMACEUTICALS INC · 2005-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Capital Expenditure: 243000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 243000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-08-001364.txt#21002 The citation records this snapshot. The page link may show a newer release later.	−USD 13.62 million Calculation and evidence -13373000 − 243000 USD Exact free cash flow: -13616000 USD 2005-01-01 – 2005-12-31: -13373000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 243000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVALON PHARMACEUTICALS INC · 2005-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Free cash flow: -13616000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13373000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-08-001364.txt#20789 Input fundies:CapitalExpenditure: 243000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-08-001364.txt#21002 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 17.1 million Exact value Exact value: -17102000 USD 2006-01-01 – 2006-12-31: -17102000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON PHARMACEUTICALS INC · 2006-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Net Income: -17102000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17102000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7694 The citation records this snapshot. The page link may show a newer release later.	−USD 11.93 million Exact value Exact value: -11932000 USD 2006-01-01 – 2006-12-31: -11932000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON PHARMACEUTICALS INC · 2006-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Operating Cash Flow: -11932000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11932000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7902 The citation records this snapshot. The page link may show a newer release later.	USD 351,000 Exact value Exact value: 351000 USD 2006-01-01 – 2006-12-31: 351000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVALON PHARMACEUTICALS INC · 2006-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Capital Expenditure: 351000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 351000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7989 The citation records this snapshot. The page link may show a newer release later.	−USD 12.28 million Calculation and evidence -11932000 − 351000 USD Exact free cash flow: -12283000 USD 2006-01-01 – 2006-12-31: -11932000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 351000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVALON PHARMACEUTICALS INC · 2006-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Free cash flow: -12283000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11932000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7902 Input fundies:CapitalExpenditure: 351000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7989 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 21.67 million Exact value Exact value: -21673000 USD 2007-01-01 – 2007-12-31: -21673000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON PHARMACEUTICALS INC · 2007-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Net Income: -21673000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21673000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7694 The citation records this snapshot. The page link may show a newer release later.	−USD 18.9 million Exact value Exact value: -18903000 USD 2007-01-01 – 2007-12-31: -18903000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON PHARMACEUTICALS INC · 2007-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Operating Cash Flow: -18903000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18903000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7902 The citation records this snapshot. The page link may show a newer release later.	USD 427,000 Exact value Exact value: 427000 USD 2007-01-01 – 2007-12-31: 427000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVALON PHARMACEUTICALS INC · 2007-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Capital Expenditure: 427000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 427000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7989 The citation records this snapshot. The page link may show a newer release later.	−USD 19.33 million Calculation and evidence -18903000 − 427000 USD Exact free cash flow: -19330000 USD 2007-01-01 – 2007-12-31: -18903000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 427000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVALON PHARMACEUTICALS INC · 2007-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Free cash flow: -19330000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18903000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7902 Input fundies:CapitalExpenditure: 427000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7989 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 21.83 million Exact value Exact value: -21827000 USD 2008-01-01 – 2008-12-31: -21827000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON PHARMACEUTICALS INC · 2008-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Net Income: -21827000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21827000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7694 The citation records this snapshot. The page link may show a newer release later.	−USD 18.44 million Exact value Exact value: -18436000 USD 2008-01-01 – 2008-12-31: -18436000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON PHARMACEUTICALS INC · 2008-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Operating Cash Flow: -18436000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18436000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7902 The citation records this snapshot. The page link may show a newer release later.	USD 270,000 Exact value Exact value: 270000 USD 2008-01-01 – 2008-12-31: 270000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVALON PHARMACEUTICALS INC · 2008-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Capital Expenditure: 270000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 270000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7989 The citation records this snapshot. The page link may show a newer release later.	−USD 18.71 million Calculation and evidence -18436000 − 270000 USD Exact free cash flow: -18706000 USD 2008-01-01 – 2008-12-31: -18436000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 270000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVALON PHARMACEUTICALS INC · 2008-12-31 AVALON PHARMACEUTICALS INC (edgar:1162192) Free cash flow: -18706000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-10T08:26:13Z Snapshot: 9fbaad38cf49c3dbe53c536c3f65428bed75256221845d943eb10b134b45cd73 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1162192?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18436000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7902 Input fundies:CapitalExpenditure: 270000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1162192/0000950133-09-000960.txt#7989 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

15 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-10. Source filing dates and reporting periods are shown separately.

Identifiers: 0001162192, 1162192, edgar:1162192

AVALON PHARMACEUTICALS INC

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation